Skip to the page

Data / Form D filings / NOVAI LTD

NOVAI LTD: Form D filing

NOVAI LTD, a biotechnology company in Reading, United Kingdom, filed a Form D with the SEC in 2023. The latest, on May 15, 2023, reports $1.1 million sold of a $1.1 million offering to 22 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
THE WHITE BUILDING, WORKLIFE, 33 KING'S ROAD, Reading, United Kingdom, RG1 3
Phone
0044 (0)20 7952 1723
Industry
Biotechnology
Entity type
Other (Private Limited)
Incorporated in
United Kingdom
Year incorporated
2020
Revenue range
$1 - $1,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1968417

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 15, 2023New notice$1,131,702$1,131,70222Jan 30, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
NATALIE ROY PANKOVADirector
STEPHEN ROY PAGEDirector
MARIA FRANCESCA CORDEIRODirector
KARL DAVID KEEGANDirector
CHRISTOPHER MARK WHEATCROFTDirector
JAMES HEDLEY RAWLINGSONDirector

Every Form D from the week of May 15, 2023 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what NOVAI LTD reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.